Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

被引：0
|
作者：
Reiners, K. S. [1 ]
Topolar, D. [1 ]
Henke, A. [1 ]
Kessler, J. [1 ]
Sauer, M. [1 ]
Hansen, H. P. [1 ]
Tawadros, S. [2 ]
Herling, M. [3 ]
Kroenke, M. [4 ,5 ]
Hallek, M. [6 ]
von Strandmann, Pogge E. [1 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50931 Cologne, Germany
[2] Univ Cologne, Dept Expt Med, D-50931 Cologne, Germany
[3] Univ Cologne, Dept Internal Med 1, Lab Lymphocyt Signaling & Oncoproteom, D-50931 Cologne, Germany
[4] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany
[5] Cluster Excellence Cellular Stress Responses Agin, Cologne, Germany
[6] Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [21] Extracellular NK histones promote immune cell anti-tumor activity by inducing cell clusters through binding to CD138 receptor
    Martin-Antonio, B.
    Sune, G.
    Najjar, A.
    Perez-Amill, L.
    Antonana-Vildosola, A.
    Castella, M.
    Leon, S.
    Velasco-de Andres, M.
    Lozano, F.
    Lozano, E.
    Bueno, C.
    Estanyol, J. M.
    Munoz-Pinedo, C.
    Robinson, S. N.
    Urbano-Ispizua, A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [22] Prevalence of soluble NKG2D ligands in leukemia and their influence on NK cell anti-leukemia reactivity
    Hilpert, J.
    Baessler, T.
    Kanz, L.
    Steinle, A.
    Salih, H. R.
    ONKOLOGIE, 2011, 34 : 197 - 198
  • [23] CpG-oligodeoxynucleotides potently activate human NK cells and sensitize chronic lymphocytic leukemia cells to NK cell-mediated killing
    Bachanova, V.
    Liang, X.
    Chan, A. S.
    Peterson, A. J.
    Chen, L. Y.
    Robertson, P. T.
    Panoskaltsis-Mortari, A.
    Blazar, B. R.
    Miller, J. S.
    Chen, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] The role of NFAT signaling in NK cell function and anti-tumor reactivity
    Wild, J.
    Schmiedel, B. J.
    Maerklin, M.
    Mueller, M. R.
    Kanz, L.
    Salih, H. R.
    ONKOLOGIE, 2012, 35 : 123 - 123
  • [25] Killing the Invaders: NK Cell Impact in Tumors and Anti-Tumor Therapy
    Molgora, Martina
    Cortez, Victor S.
    Colonna, Marco
    CANCERS, 2021, 13 (04) : 1 - 16
  • [26] Use of NK humanized mouse models for the in vivo evaluation of anti-tumor NK-cell therapies
    Rettman, Pauline
    Meyer, Laure-Marie
    Rangara, Ravi
    Ponchet-Lac, Anna
    Moindrot, Nicolas
    Biancotto, Angelique
    Lefranc, Celine
    Delahaye, Fabien
    Rabia, Emilia
    Cesaroni, Matteo
    Sidhu, Sukhvinder
    Nicolazzi, Celine
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
    Wang, Zong-Han
    Li, Wei
    Dong, Hao
    Han, Fujun
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [28] DEVELOPMENT OF WU-NK-101, A FEEDER CELL-FREE EXPANDED ALLOGENEIC MEMORY NK CELL PRODUCT WITH POTENT ANTI-TUMOR ACTIVITY
    Sullivan, Ryan
    Mathyer, Mary
    Govero, Jennifer
    Dean, John
    Martens, Andrew
    Zhou, You
    Darwech, Malik
    Tumala, Brunda
    Vessoni, Alex
    Hamil, Alexander
    Leedom, Tom
    Johnson, Corey
    Berrien-Elliot, Melissa
    Foster, Mark
    Becker-Hapak, Michelle
    McClain, Ethan
    Neal, Carly
    Fehniger, Todd
    Shrestha, Niraj
    Dee, Mike
    Wong, Hing
    Kabakibi, Ayman
    Cooper, Matthew
    Chrobak, Ken
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A200 - A200
  • [29] STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity
    Meissl, Katrin
    Amenitsch, Lena
    Witalisz-Siepracka, Agnieszka
    Klein, Klara
    Lassnig, Caroline
    Puga, Ana
    Vogl, Claus
    Poelzl, Andrea
    Bosmann, Markus
    Dohnal, Alexander
    Sexl, Veronika
    Mueller, Mathias
    Strobl, Birgit
    Simonovic, Natahja
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [30] DEFICIENCY OF NATURAL-KILLER (NK) CELL-ACTIVITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
    ZIEGLER, HWL
    KAY, NE
    ZARLING, JM
    IMMUNOBIOLOGY, 1980, 157 (03) : 301 - 301
12345